Lexeo Raises $100m To Advance CNS Candidates, Validate Cardiac Gene Therapies

Start-Up Has Brought In $185m In Less Than A Year

 
• By Mandy Jackson
  
Gene therapy concept vector illustration
Lexeo will take its first gene therapy for a rare cardiomyopathy into the clinic within the next few months • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business